B. NOTES ON ACCOUNTS:
1. Previous year figure have been re-grouped / re-arranged / re-caste wherever considered necessary, to suit the current year's layout as per the performa of Revised Schedule III.
2. In the opinion of the Board, the current assets, loans and advances have a value on realisation in the ordinary course of business atleast equal to the amount at which they are stated in the balance sheet and that the provision for known liabilities are adequate and not in excess of amount reasonably necessary.
3. EPS CALCULATION Basic earnings per share
Basic earnings per share is calculated by dividing (A) the profit/(loss) attributable to owners of the company (B) by the weighted average number of equity shares outstanding during the financial year, adjusted for bonus elements in equity shares issued during the year.
Diluted earnings per share
Diluted earnings per share adjusts the figures used in the determination of basic earnings per share to take into account:
(a) the after income tax effect of interest and other financing costs associated with dilutive potential equity shares; and
(b) the weighted average number of additional equity shares that would have been outstanding assuming the conversion of all dilutive potential equity years.
4. With reference to Employee Benefits, no provision has been made regarding Gratuity, Leave encashment and other retirement benefits and in absence of actuarial valuation there impact on financial statements are unascertainable.
5. Related Party disclosures are required under the Accounting standard (IAS-24) on "Related Party Disclosures" issued are given below:
a.) Relationship
i) Holding Company : NONE
ii) Key Management Personnel (Managing / Whole Time Director)
Sakshi Laller (Whole time Director)
Bharat Singh (CFO)
iii) Entities over which key management personnel / their Relatives are able to exercise significant influence
a) Ovation Remedies
b) Galaxy Pharmaceuticals Limited, Kenya
c) Symbiosis Pharmaceuticals Private Limited
d) Symbiosis Bioscience Private Limited
There is change in ratios as due to increase in current liabilities, losses and decreased sales as compared to previous year.
18. Others
Three bank accounts namely ICICI bank Mumbai with balance Rs 4,000/-, Union Bank of India balance Rs. 2,02,809.89/- and Bank A/C Mumbai balance Rs. 7,270/- as appearing in books of accounts on 31.03.2025 have become in-operative and balance of same cannot be confirmed
19. Rounding of has been done to nearest Lacs.
20. Disclosure of Transactions with Struck off Company
The company did not have any material transaction with companies struck off under Section 248 of the Companies Act, 2013 or Section 560 of the Companies Act, 1956 during the financial year.
21. Additional Regulatory Disclosures
No transaction to report against the following disclosures as notified by MCA Pursuant to amendment in Schedule III:
(a) Crypto Currency or virtual Currency;
(b) Benami Property held under Prohibition of Benami Transactions Act , 1988 and rules made there under;
(c) Registration of charges or satisfaction with Registrar of Companies;
(d) Compliance with number of layers of companies;
(e) Relating to Borrowed funds
(i) Wilful Defaulter;
(ii) Utilization of borrowed funds and share premium;
(iii) Borrowings obtained on the basis of security of current assets;
(iv) Discrepancy in utilization of borrowings;
(v) Current maturity of long term borrowings.
(f) Title deeds of immovable properties.
| 